Study Supports Once-Daily Plazomicin Use for Complicated UTIs
Plazomicin is superior to meropenem in treating complicated UTIs due Enterobacteriaceae not susceptible to aminoglycosides.
Diagnosis & Disease Information
UTI Risk After Urogynecologic Surgery Linked to Bladder Microbiome
Depletion of Lactobacillus iners in the bladder appears to increase the risk of urinary tract infection following urogynecologic surgery, study finds.
FDA Approves Drug for Complicated UTIs
Plazomicin, an aminoglycoside, was approved for treating complicated urinary tract infections in adults due to certain Enterobacteriaceae.
Meropenem-vaborbactam Superior for Complicated UTIs
Overall treatment success occurred in 98.4% of patients receiving meropenem-vaborbactam vs 94% for those receiving piperacillin-tazobactam.
Post-Cystectomy UTI Risk Linked to Comorbidities
A Charlson Comorbidity Index score of 2 or higher is an independent risk factor for urinary tract infections within 90 days following radical cystectomy for bladder cancer, study finds.
Bladder, Bowel Dysfunction More Likely in Girls vs Boys
New analysis finds that female sex and non-dilating vesicoureteral reflux are independently associated with an increased risk of bladder and bowel dysfunction.
Recurrent UTIs Worsen Kidney Transplant Outcomes
Kidney transplant recipients who experience recurrent urinary tract infections are at increased risk of graft failure and death.
Cipro Not Better for UTI Prophylaxis After Transplant With Stent
In a study of renal transplant patients who received ureteral stents, ciprofloxacin did not lower the incidence of UTI compared with SMX-TMP.
Bacteremia in UTI Patients Tied to Abnormal CT Findings
In a study of 189 adult UTI patients who underwent CT scans, investigators identified bacteremia in 40.2%.
- Loading...
Loading...
Next post in Urinary Tract Infections (UTI)
Loading... 
Loading...